KINGFA(SH:600143) Dongguan Securities·2026-02-26 08:00Investment Rating - The report maintains a "Buy" rating for the company [1][53]. Core Insights - The company is a leading player in the modified plastics industry, having established itself as the largest and most comprehensive producer globally over more than 30 years of development [10][53]. - Continuous R&D innovation has helped the company maintain a technological edge, with a total of 6,813 domestic and international patents applied by the end of 2024, placing it at the forefront of the industry [3][40]. - The company is advancing a globalization strategy, establishing production bases in various countries, including the USA, Germany, and India, which has led to rapid growth in foreign sales revenue [3][48]. - The company is enhancing its product structure by integrating the supply chain, moving from single modified plastics to a variety of new chemical materials, thereby increasing its high-end and high-value-added product offerings [3][44]. - A mid-to-long-term incentive mechanism is in place to attract and retain talent, which is crucial for achieving the company's strategic goals [3][43]. Summary by Sections 1. Company Overview - The company was founded in 1993 and listed on the Shanghai Stock Exchange in 2004, forming strategic partnerships with numerous well-known domestic and international enterprises [10]. - The main business includes R&D, production, and sales of chemical new materials, with modified plastics accounting for 53% of total revenue in 2024 [12]. 2. Industry Development - The modified plastics industry benefits from rapid growth in emerging downstream markets, supported by favorable policies that promote technological innovation and application [17][23]. - The production of modified plastics in China has increased from 22.5 million tons in 2020 to 33.2 million tons in 2024, with a compound annual growth rate of 10% [30]. 3. R&D and Cost Efficiency - The company has established a "13551" R&D system, with a focus on continuous technological accumulation and product research, employing 1,622 R&D personnel by the end of 2024 [37][40]. - R&D expenses reached 2.49 billion yuan in 2024, reflecting a year-on-year growth of 26.2% [40]. 4. Globalization Strategy - The company is committed to a globalization strategy, with production bases established in multiple countries, enhancing its global competitiveness [47][50]. - In the first half of 2025, the company achieved a 33.2% year-on-year increase in overseas product sales [50]. 5. Financial Projections - The company forecasts earnings per share of 0.46 yuan, 0.69 yuan, and 0.80 yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 42x, 28x, and 24x [53][54].